Skip to Main Content

Paper Details

Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.
Haematologica
14
2017
- leukemic cells, 4-hydroperoxycyclophosphamide, 4-hydroxynonenal, ALDH, ALDH1A1, ALDH1A1- cell lines, ALDH1A1- leukemias, ALDH1A1- leukemic cells, Aldehyde, Aldehyde dehydrogenase 1A1, acute myeloid leukemias, aldehyde, aldehyde dehydrogenase 1A1, aldehydes, arsenic, arsenic trioxide, cyclophosphamide, hematopoietic stem cells, leukemias, myeloid leukemias, normal hematopoietic stem cells, primary leukemia cells, stem cells
Author NameAffiliation
Maura GasparettoUniversity of Colorado
Shanshan PeiUniversity of Colorado
Mohammad MinhajuddinUniversity of Colorado
Daniel A PollyeaUniversity of Colorado
Michael W BeckerUniversity of Rochester Medical Center
Veronica Clavijo JordanUniversity of Colorado
Veronica Clavijo JordanUniversity of Colorado
Clayton A SmithUniversity of Colorado
  • 1 - 8

Datasets

Release 1.2